Don information (evidence) like the mega-studies in the US carry any significance as a countermeasure to generic drugs?
A11. In the US, 70~80% of drugs become generic drugs within a year after the patents expire. Authorized generics is perhaps possible as a countermeasure to generic drugs, however, the situation in the US is that evidence like mega-studies are utilized not for Mevalotin but for Pravastatin drug overall.
Related Questions
- What is the extent of impact of generic products in Japan? Also, what kinds of countermeasure to generic drugs are there?
- Don information (evidence) like the mega-studies in the US carry any significance as a countermeasure to generic drugs?
- Are generic drugs the same as name brand drugs? Is Docetaxel available in generic form?
